
|Slideshows|February 16, 2021
- MHE February 2021
- Volume 31
- Issue 2
Challenges Ahead in 2021
Author(s)MHE Staff
COVID-19 is the biggest one, but other twists and turns await.
Advertisement
We conducted our Challenges Ahead reader survey in January and had 101 respondents. Their answers provide understanding and insight into the thinking of healthcare executives about what lies ahead for them, their organizations and the country in 2021. Many thanks to everyone who participated!
Articles in this issue
almost 5 years ago
Does the U.S. Have a Shortage of Physicians?almost 5 years ago
Risky Business: Only Three of the ACA’s 23 co-ops Remainalmost 5 years ago
How ‘White Bagging’ Affects Patients, Physicians and 340B Fundingalmost 5 years ago
SDOH: How They Affect Cancer Rates, Care and Paymentalmost 5 years ago
Interoperability is Coming — at Lastalmost 5 years ago
Using Behavioral Economics to Influence Healthcare Decisionsalmost 5 years ago
Next Gen ACOs: Savers or Spenders?almost 5 years ago
COVID Vaccines OK for Immunocompromisedalmost 5 years ago
Plot Twists for ‘Mabs’ as COVID-19 TreatmentNewsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Music and painting dual art therapy improves cognitive and social functions of hospitalized schizophrenia patients, study suggests
2
Biosimilars in 2025: A year of firsts
3
Looking ahead: What the MHE 2025 State of the Industry survey tells us about 2026
4
Japanese study finds vitiligo has a strong impact on daily life and mental health
5






















































